InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Explore the detailed record of transactions filed by Jenusaitis Matthew, Director. Officer active across 1 companies, notably Hancock Jaffe Laboratories, Inc.. In total, 4 disclosures have been logged. Total volume traded: €17k. The latest transaction was filed on 25 August 2021 — Acquisition. Regulator: SEC (Form 4). All data is free.
Declarations4 total
1,042 shares
Common Stock
SEC:0001493152-21-022863·
1,042 shares
Common Stock
SEC:0001493152-21-022863:0·
€8,5011,300 shares@ €6.5396100.0% of flow
Common Stock, $$0.00001 par value
SEC:0001493152-21-021444·
Ideal exit: 22 May 2022 (T+270)
€8,5011,300 shares@ €6.539650.0% of flow
Common Stock, $$0.00001 par value
SEC:0001493152-21-021444:0·
Ideal exit: 22 May 2022 (T+270)
4 of 4 declarations
About Jenusaitis Matthew
Jenusaitis Matthew is a Board Member at Hancock Jaffe Laboratories, Inc. He actively participates in strategic decisions and oversight of the company's operations. His experience in the medical sector is an asset for Hancock Jaffe.
